AAV humoral immunity Bioelectrical impedance analysis Myositis Autoantibodies Auto-antibodies Inclusion body myositis Active Cancer Prognosis Middle Aged AAV vectors Skeletal muscle Adeno-associated virus Autoimmunity AAV vector Interstitial lung disease Biomarker Anti‐mitochondrial antibodies Acid-alpha-glucosidase Antisynthetase Assisted communication devices Muscle Biomarqueurs Lysosomal storage diseases Immune checkpoint inhibitors Immunotherapy Adeno-associated virus vector Multidisciplinarity Antibodies Analyses multidimensionnelles Agalsidase Adverse drug reactions B-lymphocyte Myositis and muscle disease Dermatomyositis Myopathy Anti-agalsidase antibodies IMNM Inborn errors of metabolism Pharmacology Aldosterone Machine learning Amyotrophy Adult Deep immune profiling COVID-19 B cell homeostasis Inflammatory myopathy Anti-synthetase syndrome Anticorps anti-agalsidase Interferon Outcome measures Antisynthétase Fabry disease Auto-immunité AAV Autoimmune diseases Case reports Humans Biomarkers Anti-MDA5 autoantibodies IBM Anti-drug antibodies Autoantibody DM Gene therapy Adjudication Mass cytometry Systems biology Abnormal movement AAV antibody Aged Aldostérone Acute Kidney Injury/epidemiology/etiology Myocarditis Amyotrophic lateral sclerosis Data integration Cytokines Animals Antisynthetase syndrome Adolescence Polymyositis Arthritis Antibody responses Anti-interleukin-6 Sphingosine-1-phosphate Antiphospholipid syndrome Adeno-associated vector Anti-Mi2 Idiopathic inflammatory myopathies Biopsy Anti-IgE IgG Female Anticorps spécifique des myosites Cardio-oncology Dependovirus/genetics/immunology Inflammation Anémie hémolytique Male Auto‐antibodies